TrialBMC infectious diseases2018

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial.

Tomas Reischig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.